RAPAFLO
RAPAFLO® (silodosin) Capsules These highlights do not include all the information needed to use RAPAFLO® safely and effectively. See full prescribing information for RAPAFLO. RAPAFLO® (silodosin) capsule for oral useInitial U.S. Approval: 2008
Approved
Approval ID
96425d91-cfe1-477d-a130-b58c330ca8a3
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 15, 2012
Manufacturers
FDA
Physicians Total Care, Inc.
DUNS: 194123980
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
silodosin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code54868-6173
Application NumberNDA022206
Product Classification
M
Marketing Category
C73594
G
Generic Name
silodosin
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 15, 2012
FDA Product Classification
INGREDIENTS (1)
SILODOSINActive
Quantity: 8 mg in 1 1
Code: CUZ39LUY82
Classification: ACTIM